Impact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer.
Rep Pract Oncol Radiother
; 25(4): 463-469, 2020.
Article
de En
| MEDLINE
| ID: mdl-32494221
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Etiology_studies
/
Risk_factors_studies
Langue:
En
Journal:
Rep Pract Oncol Radiother
Année:
2020
Type de document:
Article